Myotonic Dystrophy Industry Updates was presented in partnership by Euro-DyMA (European Dystrophia Myotonica Association) and the Myotonic Dystrophy Foundation (MDF) as a part of the 2025 MDF Conference on May 2nd and 3rd, 2025.

Click here to learn more about 2025 MDF Conference in Indianapolis, Indiana! >>>

In this session, representatives from biotech and pharma companies provide updates on their drug development efforts in the DM field.

Presenting organizations include:

• Avidity Biosciences
• Dyne Therapeutics
• ARTHEx Biotech
• Juvena Therapeutics
• Lupin Neurosciences
• PepGen
• Vertex Pharmaceuticals
• Sanofi
• Modalis Therapeutics
• Arrakis Therapeutics

Thank you to our 2025 MDF Conference Sponsors for helping make this event possible:

• Lead Sponsor: Avidity Biosciences
• Diamond Sponsors: Dyne Therapeutics and Arthex Biotech
• Platinum Sponsors: PepGen and Vertex Pharmaceuticals
• Gold Sponsor: Sanofi
• Bronze Sponsor: Lupin Neurosciences